Patents by Inventor Stefan Spaniol
Stefan Spaniol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9040079Abstract: A special photosensitizer formulation and Photodynamic Therapy method for treating choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD) is provided. CNV is a major cause for vision loss in elderly patients. A special drug delivery formulation is used to encapsulate the hydrophobic photosensitizer, preferably a pegylated liposome. This improves the solubility and therapeutic index of the photosensitizers. In one preferred embodiment, a pegylated photoactive agent remains confined in the intravascular compartment of neovasculature for a longer duration. Thus efficient elimination of neovascular proliferation and minimal damage to extravascular tissue and normal vessels is ensured. In this method, a hydrophobic photosensitizer, that is able to photochemically destroy neovessels, is injected into the patient. CNV irradiation with a non-thermal laser follows after a predefined time interval.Type: GrantFiled: November 19, 2008Date of Patent: May 26, 2015Assignee: Biolitec Pharma Marketing LtdInventors: Volker Albrecht, Stefan Spaniol, Dietrich Scheglmann
-
Patent number: 8834458Abstract: The invention relates to a system for medicinal treatment, in particular for treating benign prostatic hyperplasia BPH, for use in the event of tumor resection or for use in thoracic surgery. The system comprises a diode laser device for producing a laser beam and to an application system based on optical wave guides that can be endoscopically introduced into a patient. Said system is designed in such a manner that the laser beam, produced by the diode laser device is guided through the application system and is emitted by said application system so that biological tissue can be treated in a selective manner with the emerging laser beam.Type: GrantFiled: June 16, 2008Date of Patent: September 16, 2014Assignee: Biolitec Pharma Marketing LtdInventors: Wolfgang Neuberger, Stefan Spaniol, Thomas Sandrock, Endrik Groenhoff
-
Patent number: 8292935Abstract: A method and device used for treating body cells affected by abnormal cell growth or by oncogenic viruses. In particular the invention relates to photonic device for treating gynecological problems comprising at least one light source incorporated into the irradiation head or into the hand piece or as a external unit connected by light guide. The light source used in the photonic device has a LED, Laser or lamps. This photonic device is used for treating a subject having unwanted cell proliferation, example dysplasia of the portio and/or cervix with Photodynamic therapy (PDT). The advantage of using LED device is, for its radiation safety, cost effectiveness and is easy to handle compared to laser system. A drug applicator is also described which is employed for homogenously application of photoactive drug in the affected area.Type: GrantFiled: August 31, 2007Date of Patent: October 23, 2012Assignee: Bistitec Pharma Marketing LtdInventors: Wolfgang Neuberger, Stefan Spaniol
-
Publication number: 20100247626Abstract: A special photosensitizer formulation and Photodynamic Therapy method for treating choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD) is provided. CNV is a major cause for vision loss in elderly patients. A special drug delivery formulation is used to encapsulate the hydrophobic photosensitizer, preferably a pegylated liposome. This improves the solubility and therapeutic index of the photosensitizers. In one preferred embodiment, a pegylated photoactive agent remains confined in the intravascular compartment of neovasculature for a longer duration. Thus efficient elimination of neovascular proliferation and minimal damage to extravascular tissue and normal vessels is ensured. In this method, a hydrophobic photosensitizer, that is able to photochemically destroy neovessels, is injected into the patient. CNV irradiation with a non-thermal laser follows after a predefined time interval.Type: ApplicationFiled: November 19, 2008Publication date: September 30, 2010Inventors: Volker Albrecht, Stefan Spaniol, Dietrich Scheglmann
-
Publication number: 20100179523Abstract: The invention relates to a system for medicinal treatment, in particular for treating benign prostatic hyperplasia BPH, for use in the event of tumor resection or for use in thoracic surgery. The system comprises a diode laser device for producing a laser beam and to an application system based on optical wave guides that can be endoscopically introduced into a patient. Said system is designed in such a manner that the laser beam, produced by the diode laser device is guided through the application system and is emitted by said application system so that biological tissue can be treated in a selective manner with the emerging laser beam.Type: ApplicationFiled: June 16, 2008Publication date: July 15, 2010Applicant: CERAMOPTEC INDUSTRIES, INC.Inventors: Wolfgang Neuberger, Stefan Spaniol, Thomas Sandrock, Endrik Groenhoff
-
Publication number: 20090210038Abstract: A high power density light delivery device is presented that uses an optical fiber with a diffuser attached at a distal end for use in, for example, photodynamic therapy (PDT) and laser induced thermotherapy (LITT). Uniform scattering in the diffuser section is obtained by either inducing differences in refractive index profiles of the core or in the core-cladding interface with the use of scattering centers or nano-voids. Nano-voids are created in the core or core-cladding interface by focusing high power laser energy or picosecond/femtosecond laser pulses on the quartz fiber material to induce defects. A special method is used that writes defects into or near to the core/cladding boundary through the jacket, without the necessity to first remove the jacket and then recoat the fiber. The method uses a wavelength that is highly transmissive in the jacket and fiber but absorbed in the fiber at very short laser pulses with high peak power.Type: ApplicationFiled: August 22, 2007Publication date: August 20, 2009Inventors: Wolfgang Neuberger, Stefan Spaniol
-
Patent number: 7351242Abstract: An active endoscopic system is disclosed containing an electromagnetic radiation system located at the distal end of the endoscopic device allowing for variable intensity application of desired wavelengths in the application of PhotoDynamic Therapy (PDT) over a broad area. The power sources are varied according to the needs of a specific application. Various attachments and configurations may be used to enhance performance of a desired application, including but not limited to multi-balloon systems for centering the apparatus or limiting the treatment area, fiber optics for directly viewing the treatment area, vacuum systems for waste removal, tubes for delivering aminolevulinic acid (ALA) or other photosensitizers, and other fiber optics for illumination of treatment area.Type: GrantFiled: July 6, 2000Date of Patent: April 1, 2008Assignee: CeramOptec Industries, Inc.Inventors: Wolfgang Neuberger, Stefan Spaniol
-
Publication number: 20080065003Abstract: A method and device used for treating body cells affected by abnormal cell growth or by oncogenic viruses. In particular the invention relates to photonic device for treating gynecological problems comprising at least one light source incorporated into the irradiation head or into the hand piece or as a external unit connected by light guide. The light source used in the photonic device has a LED, Laser or lamps. This photonic device is used for treating a subject having unwanted cell proliferation, example dysplasia of the portio and/or cervix with Photodynamic therapy (PDT).The advantage of using LED device is, for its radiation safety, cost effectiveness and is easy to handle compared to laser system. A drug applicator is also described which is employed for homogenously application of photoactive drug in the affected area.Type: ApplicationFiled: August 31, 2007Publication date: March 13, 2008Inventors: Wolfgang Neuberger, Stefan Spaniol
-
Patent number: 7005623Abstract: Briefly stated, the present invention discloses a novel device that automatically calibrates and adjusts the intensity, dosage, and other parameters of a radiation delivery system and radiation source based on selected or detected radiation delivery systems. Such radiation delivery systems include optical fiber systems, and any type of diffuser, as well as bare fiber tips. The functions of a radiation source and a calibration device are combined by storing the characteristics of a wide variety of delivery system types and brands and calibrating the radiation based on those stored characteristics. In a preferred embodiment, a calibration sheath is provided that fits over a delivery system, such as a bare fiber tip or a diffuser at the distal end of a fiber, to both protect the system during calibration and direct output radiation to a detector.Type: GrantFiled: May 15, 2003Date of Patent: February 28, 2006Assignee: CeramOptec Industries, Inc.Inventors: Wolfgang Neuberger, Stefan Spaniol
-
Patent number: 6953288Abstract: A safe connection system for coupling radiation from radiation sources, such as lasers, into optical fibers is provided. The system prevents the accidental use of standard optical fibers with radiation sources that require fibers capable of transmitting high power or other radiation with unique characteristics. Because often the fibers for use with high power lasers, for example, may also be used with standard lasers, the system preserves the interchangeability of standard connection systems such as SMA by providing connectors that can properly fit both in standard receptacles and in the receptacles of the present invention. Thus, this connection system preserves the advantages of a standard laser-fiber connection system while increasing the safety of such systems, where it is necessary.Type: GrantFiled: April 25, 2003Date of Patent: October 11, 2005Assignee: CeramOptec Industries, Inc.Inventors: Brian Foley, Wolfgang Neuberger, Heinrich Kudla, Stefan Spaniol
-
Publication number: 20040227056Abstract: Briefly stated, the present invention discloses a novel device that automatically calibrates and adjusts the intensity, dosage, and other parameters of a radiation delivery system and radiation source based on selected or detected radiation delivery systems. Such radiation delivery systems include optical fiber systems, and any type of diffuser, as well as bare fiber tips. The functions of a radiation source and a calibration device are combined by storing the characteristics of a wide variety of delivery system types and brands and calibrating the radiation based on those stored characteristics. In a preferred embodiment, a calibration sheath is provided that fits over a delivery system, such as a bare fiber tip or a diffuser at the distal end of a fiber, to both protect the system during calibration and direct output radiation to a detector.Type: ApplicationFiled: May 15, 2003Publication date: November 18, 2004Applicant: CeramOptec Industries, Inc.Inventors: Wolfgang Neuberger, Stefan Spaniol
-
Publication number: 20040213524Abstract: A safe connection system for coupling radiation from radiation sources, such as lasers, into optical fibers is provided. The system prevents the accidental use of standard optical fibers with radiation sources that require fibers capable of transmitting high power or other radiation with unique characteristics. Because often the fibers for use with high power lasers, for example, may also be used with standard lasers, the system preserves the interchangeability of standard connection systems such as SMA by providing connectors that can properly fit both in standard receptacles and in the receptacles of the present invention. Thus, this connection system preserves the advantages of a standard laser-fiber connection system while increasing the safety of such systems, where it is necessary.Type: ApplicationFiled: April 25, 2003Publication date: October 28, 2004Applicant: CeramOptec Industries, Inc.Inventors: Brian Foley, Wolfgang Neuberger, Heinrich Kudla, Stefan Spaniol
-
Patent number: 6527764Abstract: The present invention provides a device and method for a laser treatment that couples surgical or activating laser power with a biomodulating power to enhance proper tissue healing and regeneration after treatment. This treatment is achieved using an optical fiber system delivering laser power from two separate laser sources. One source provides laser energy at a power level and density suitable for the surgical or activation action desired. The second source produces laser power at a wavelength suitable for producing biomodulating effects in the treated tissue. Biomodulation treatment of the tissue promotes cellular healing and regeneration and ensures that proper healing occurs. In addition, the present invention describes a method by which the device is used for treatment. The surgical or activating laser energy is applied to a site as the device is passed over the treatment area.Type: GrantFiled: December 2, 1999Date of Patent: March 4, 2003Assignee: CeramOptec Industries, Inc.Inventors: Wolfgang Neuberger, Stefan Spaniol
-
Publication number: 20030028227Abstract: A pharmaceutical composition, method and apparatus for treatment, diagnosis or both treatment and treatment of hyperproliferative malignant and non-malignant diseases of epithelial tissues is disclosed. The invention comprises local application of the pharmaceutical composition to a predetermined area of the tissue characterized by complete and consistent coverage of the tissue, including irregularly shaped tissue. The pharmaceutical composition consists of an active component, such as a photosensitizer or a precursor thereof, and at least one carrier substance including a viscous fluid, a gel, or a fluid that becomes viscous upon contact with the tissue. The gel's viscosity allows it to adhere to the tissue for a sufficient amount of time to transfer the photosensitizer or precursor. In a preferred embodiment the pharmaceutical composition is sprayed onto the surface of the diseased tissue.Type: ApplicationFiled: August 20, 2002Publication date: February 6, 2003Applicant: CeramOptec Industries Inc.Inventors: Wolfgang Neuberger, Stefan Spaniol, Hans-Peter Bode, Thierry Patrice, Ludovic Bourre
-
Patent number: 6421361Abstract: A tunable medical laser diode system for activating PhotoDynamic Therapy (PDT) compounds is disclosed. A tunable medical laser diode system for activating PhotoDynamic Therapy (PDT) compounds and other moderate or low energy multiple wavelength applications is disclosed. Interchangeable diode laser cartridges are used. Each cartridge contains a diode laser, which consists of at least one diode or diode array or some combination thereof. Typically, each diode laser cartridge is tuned to a different wavelength. Multiple cartridges, however may be tuned to the same wavelength for some applications One or more cartridges are attached to the system base unit simultaneously. The cartridges may be powered in series or in tandem for different applications. Selectively powering these cartridges causes light to be emitted at a certain wavelength or wavelengths. Selection of cartridges is facilitated by a drug identification scanner which scans drug activation wavelength information into the system.Type: GrantFiled: June 22, 1999Date of Patent: July 16, 2002Assignee: CeramOptec Industries, Inc.Inventors: Wolfgang Neuberger, Stefan Spaniol